RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hansoh Pharmaceutical Group Company Stock

Hansoh Pharmaceutical Group Company ROA 2024

Hansoh Pharmaceutical Group Company ROA

0.1

Ticker

3692.HK

ISIN

KYG549581067

WKN

A2PLRC

In 2024, Hansoh Pharmaceutical Group Company's return on assets (ROA) was 0.1, a 15.19% increase from the 0.09 ROA in the previous year.

Hansoh Pharmaceutical Group Company Aktienanalyse

What does Hansoh Pharmaceutical Group Company do?

The Hansoh Pharmaceutical Group Co Ltd is a leading company in the pharmaceutical industry in China. It was founded in 1995 and has its headquarters in Lianyungang, with branches in Beijing and Shanghai. The company specializes in developing and producing innovative drugs for various diseases. It invests significant resources in research and development, collaborating with renowned research institutes and universities. Hansoh has a wide range of products in areas such as oncology, anesthesia, antibiotics, anti-infectives, and cardiovascular diseases. It has expanded its research and development activities in recent years and has partnerships with other pharmaceutical companies. The company mainly sells its products to hospitals and medical facilities in China. It is committed to strong corporate governance and sustainability, and it has been recognized for its environmental initiatives. Overall, Hansoh Pharmaceutical Group Co Ltd is a major player in the Chinese pharmaceutical industry. Hansoh Pharmaceutical Group Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Hansoh Pharmaceutical Group Company's Return on Assets (ROA)

Hansoh Pharmaceutical Group Company's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Hansoh Pharmaceutical Group Company's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Hansoh Pharmaceutical Group Company's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Hansoh Pharmaceutical Group Company’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Hansoh Pharmaceutical Group Company stock

What is the Return on Assets (ROA) of Hansoh Pharmaceutical Group Company this year?

The Return on Assets (ROA) of Hansoh Pharmaceutical Group Company is 0.1 undefined this year.

What was the ROA of Hansoh Pharmaceutical Group Company compared to the previous year?

The ROA of Hansoh Pharmaceutical Group Company has increased by 15.19% compared to the previous year.

What consequences do high ROA have for investors of Hansoh Pharmaceutical Group Company?

A high ROA is advantageous for investors of Hansoh Pharmaceutical Group Company, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Hansoh Pharmaceutical Group Company?

A low ROA can be unfavorable for investors of Hansoh Pharmaceutical Group Company as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Hansoh Pharmaceutical Group Company affect the company?

An increase in ROA of Hansoh Pharmaceutical Group Company can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Hansoh Pharmaceutical Group Company impact the company?

A reduction in the ROA of Hansoh Pharmaceutical Group Company can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Hansoh Pharmaceutical Group Company?

Some factors that can influence the ROA of Hansoh Pharmaceutical Group Company include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Hansoh Pharmaceutical Group Company important for investors?

The ROA of Hansoh Pharmaceutical Group Company is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Hansoh Pharmaceutical Group Company take to improve ROA?

To improve ROA, Hansoh Pharmaceutical Group Company can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Hansoh Pharmaceutical Group Company pay?

Over the past 12 months, Hansoh Pharmaceutical Group Company paid a dividend of 0.19 CNY . This corresponds to a dividend yield of about 1.15 %. For the coming 12 months, Hansoh Pharmaceutical Group Company is expected to pay a dividend of 0.2 CNY.

What is the dividend yield of Hansoh Pharmaceutical Group Company?

The current dividend yield of Hansoh Pharmaceutical Group Company is 1.15 %.

When does Hansoh Pharmaceutical Group Company pay dividends?

Hansoh Pharmaceutical Group Company pays a quarterly dividend. This is distributed in the months of October, July, October, July.

How secure is the dividend of Hansoh Pharmaceutical Group Company?

Hansoh Pharmaceutical Group Company paid dividends every year for the past 0 years.

What is the dividend of Hansoh Pharmaceutical Group Company?

For the upcoming 12 months, dividends amounting to 0.2 CNY are expected. This corresponds to a dividend yield of 1.23 %.

In which sector is Hansoh Pharmaceutical Group Company located?

Hansoh Pharmaceutical Group Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hansoh Pharmaceutical Group Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hansoh Pharmaceutical Group Company from 7/17/2024 amounting to 0.142 CNY, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did Hansoh Pharmaceutical Group Company pay the last dividend?

The last dividend was paid out on 7/17/2024.

What was the dividend of Hansoh Pharmaceutical Group Company in the year 2023?

In the year 2023, Hansoh Pharmaceutical Group Company distributed 0.23 CNY as dividends.

In which currency does Hansoh Pharmaceutical Group Company pay out the dividend?

The dividends of Hansoh Pharmaceutical Group Company are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hansoh Pharmaceutical Group Company

Our stock analysis for Hansoh Pharmaceutical Group Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hansoh Pharmaceutical Group Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.